SP
Syndax Pharmaceuticals Inc
🇺🇸XNAS.SNDXUnited StatesHealthcare
$18.00USDdown -0.35 (-1.91%)OpenEnd of day5:13 PM
Price$18.00-0.35 (-1.91%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US87164F1057
- CUSIP
- 87164F105
Company
- Employees
- 298
- Headquarters
- New York, United States
- Website
- https://syndax.com
- CEO
- Mr. Michael A. Metzger M.B.A.
Market
- Shares outstanding
- 89.3M
- Market cap
- $1.61B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $1.61B
- EPS LTM
- -$2.47calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -7.28calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $252M+222.34%up year on year
- Net income
- -$220.77M+34.1%up year on year
- Gross margin
- 97.47%+1.35%up year on year
- Free cash flow
- -$220.87M+27.03%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.